Literature DB >> 26590883

Novel FANCI mutations in Fanconi anemia with VACTERL association.

Sharon A Savage1, Bari J Ballew1, Neelam Giri1, Settara C Chandrasekharappa2, Najim Ameziane3, Johan de Winter3, Blanche P Alter1.   

Abstract

Fanconi anemia (FA) is an inherited bone marrow failure syndrome caused by mutations in DNA repair genes; some of these patients may have features of the VACTERL association. Autosomal recessive mutations in FANCI are a rare cause of FA. We identified FANCI mutations by next generation sequencing in three patients in our FA cohort among several whose mutated gene was unknown. Four of the six mutations are novel and all mutations are likely deleterious to protein function. There are now 16 reported cases of FA due to FANCI of whom 7 have at least 3 features of the VACTERL association (44%). This suggests that the VACTERL association in patients with FA may be seen in patients with FANCI mutations more often than previously recognized.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FANCI; Fanconi anemia; VACTERL association

Mesh:

Substances:

Year:  2015        PMID: 26590883      PMCID: PMC7158112          DOI: 10.1002/ajmg.a.37461

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair.

Authors:  Luca Colnaghi; Mathew J K Jones; Xiomaris M Cotto-Rios; Detlev Schindler; Helmut Hanenberg; Tony T Huang
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

2.  VACTERL-H Association and Fanconi Anemia.

Authors:  B P Alter; P S Rosenberg
Journal:  Mol Syndromol       Date:  2013-02

3.  Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia.

Authors:  Asuka Hira; Kenichi Yoshida; Koichi Sato; Yusuke Okuno; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Akira Shimamoto; Hidetoshi Tahara; Etsuro Ito; Seiji Kojima; Hitoshi Kurumizaka; Seishi Ogawa; Minoru Takata; Hiromasa Yabe; Miharu Yabe
Journal:  Am J Hum Genet       Date:  2015-06-04       Impact factor: 11.025

4.  Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.

Authors:  Sarah L Sawyer; Lei Tian; Marketta Kähkönen; Jeremy Schwartzentruber; Martin Kircher; Jacek Majewski; David A Dyment; A Micheil Innes; Kym M Boycott; Lisa A Moreau; Jukka S Moilanen; Roger A Greenberg
Journal:  Cancer Discov       Date:  2014-12-03       Impact factor: 39.397

5.  Treatment of the bone marrow failure in Fanconi anemia patients with danazol.

Authors:  Kathrin Scheckenbach; Mary Morgan; Judith Filger-Brillinger; Matthias Sandmann; Bruce Strimling; Wolfram Scheurlen; Detlev Schindler; Ulrich Göbel; Helmut Hanenberg
Journal:  Blood Cells Mol Dis       Date:  2011-12-16       Impact factor: 3.039

Review 6.  Pathophysiology and management of inherited bone marrow failure syndromes.

Authors:  Akiko Shimamura; Blanche P Alter
Journal:  Blood Rev       Date:  2010-04-24       Impact factor: 8.250

7.  Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.

Authors:  Bari J Ballew; Meredith Yeager; Kevin Jacobs; Neelam Giri; Joseph Boland; Laurie Burdett; Blanche P Alter; Sharon A Savage
Journal:  Hum Genet       Date:  2013-01-18       Impact factor: 4.132

8.  Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.

Authors:  Settara C Chandrasekharappa; Francis P Lach; Danielle C Kimble; Aparna Kamat; Jamie K Teer; Frank X Donovan; Elizabeth Flynn; Shurjo K Sen; Supawat Thongthip; Erica Sanborn; Agata Smogorzewska; Arleen D Auerbach; Elaine A Ostrander
Journal:  Blood       Date:  2013-04-23       Impact factor: 22.113

9.  Functional ex vivo assay to select homologous recombination-deficient breast tumors for PARP inhibitor treatment.

Authors:  Kishan A T Naipal; Nicole S Verkaik; Najim Ameziane; Carolien H M van Deurzen; Petra Ter Brugge; Matty Meijers; Anieta M Sieuwerts; John W Martens; Mark J O'Connor; Harry Vrieling; Jan H J Hoeijmakers; Jos Jonkers; Roland Kanaar; Johan P de Winter; Maaike P Vreeswijk; Agnes Jager; Dik C van Gent
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

10.  Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1.

Authors:  Hande Kocak; Bari J Ballew; Kamlesh Bisht; Rebecca Eggebeen; Belynda D Hicks; Shalabh Suman; Adri O'Neil; Neelam Giri; Ivan Maillard; Blanche P Alter; Catherine E Keegan; Jayakrishnan Nandakumar; Sharon A Savage
Journal:  Genes Dev       Date:  2014-09-18       Impact factor: 12.890

View more
  8 in total

1.  Genetic Testing in a Cohort of Complex Esophageal Atresia.

Authors:  Eliane Beauregard-Lacroix; Jessica Tardif; Emmanuelle Lemyre; Zoha Kibar; Christophe Faure; Philippe M Campeau
Journal:  Mol Syndromol       Date:  2017-06-16

2.  Phenotypic Characteristics and Copy Number Variants in a Cohort of Colombian Patients with VACTERL Association.

Authors:  Olga M Moreno; Ana I Sánchez; Angélica Herreño; Gustavo Giraldo; Fernando Suárez; Juan Carlos Prieto; Ana Shaia Clavijo; Mercedes Olaya; Yaris Vargas; Javier Benítez; Jordi Surallés; Adriana Rojas
Journal:  Mol Syndromol       Date:  2020-11-11

3.  Heterozygous loss of WBP11 function causes multiple congenital defects in humans and mice.

Authors:  Ella M M A Martin; Annabelle Enriquez; Duncan B Sparrow; David T Humphreys; Aideen M McInerney-Leo; Paul J Leo; Emma L Duncan; Kavitha R Iyer; Joelene A Greasby; Eddie Ip; Eleni Giannoulatou; Delicia Sheng; Elizabeth Wohler; Clémantine Dimartino; Jeanne Amiel; Yline Capri; Daphné Lehalle; Adi Mory; Yael Wilnai; Yael Lebenthal; Ali G Gharavi; Grażyna G Krzemień; Monika Miklaszewska; Robert D Steiner; Cathy Raggio; Robert Blank; Hagit Baris Feldman; Hila Milo Rasouly; Nara L M Sobreira; Rebekah Jobling; Christopher T Gordon; Philip F Giampietro; Sally L Dunwoodie; Gavin Chapman
Journal:  Hum Mol Genet       Date:  2020-12-04       Impact factor: 6.150

4.  FANCI functions as a repair/apoptosis switch in response to DNA crosslinks.

Authors:  Richa B Shah; Jennifer L Kernan; Anya van Hoogstraten; Kiyohiro Ando; Yuanyuan Li; Alicia L Belcher; Ivy Mininger; Andrei M Bussenault; Renuka Raman; Ramanagouda Ramanagoudr-Bhojappa; Tony T Huang; Alan D D'Andrea; Settara C Chandrasekharappa; Aneel K Aggarwal; Ruth Thompson; Samuel Sidi
Journal:  Dev Cell       Date:  2021-07-12       Impact factor: 13.417

5.  Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients.

Authors:  Minako Mori; Asuka Hira; Kenichi Yoshida; Hideki Muramatsu; Yusuke Okuno; Yuichi Shiraishi; Michiko Anmae; Jun Yasuda; Shu Tadaka; Kengo Kinoshita; Tomoo Osumi; Yasushi Noguchi; Souichi Adachi; Ryoji Kobayashi; Hiroshi Kawabata; Kohsuke Imai; Tomohiro Morio; Kazuo Tamura; Akifumi Takaori-Kondo; Masayuki Yamamoto; Satoru Miyano; Seiji Kojima; Etsuro Ito; Seishi Ogawa; Keitaro Matsuo; Hiromasa Yabe; Miharu Yabe; Minoru Takata
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

6.  Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.

Authors:  Piers Blombery; Lucy Fox; Georgina L Ryland; Ella R Thompson; Jennifer Lickiss; Michelle McBean; Satwica Yerneni; David Hughes; Anthea Greenway; Francoise Mechinaud; Erica M Wood; Graham J Lieschke; Jeff Szer; Pasquale Barbaro; John Roy; Joel Wight; Elly Lynch; Melissa Martyn; Clara Gaff; David Ritchie
Journal:  Haematologica       Date:  2021-01-01       Impact factor: 9.941

7.  A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.

Authors:  Caitlin T Fierheller; Laure Guitton-Sert; Wejdan M Alenezi; Timothée Revil; Kathleen K Oros; Yuandi Gao; Karine Bedard; Suzanna L Arcand; Corinne Serruya; Supriya Behl; Liliane Meunier; Hubert Fleury; Eleanor Fewings; Deepak N Subramanian; Javad Nadaf; Jeffrey P Bruce; Rachel Bell; Diane Provencher; William D Foulkes; Zaki El Haffaf; Anne-Marie Mes-Masson; Jacek Majewski; Trevor J Pugh; Marc Tischkowitz; Paul A James; Ian G Campbell; Celia M T Greenwood; Jiannis Ragoussis; Jean-Yves Masson; Patricia N Tonin
Journal:  Genome Med       Date:  2021-12-03       Impact factor: 11.117

Review 8.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.